Navigation Links
Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
Date:9/30/2009

SCHAUMBURG, Ill., Sept. 30 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched vinorelbine injection, USP, an anti-mitotic chemotherapy drug. According to IMS, 2008 sales of vinorelbine injection, USP in the United States approximated $17 million. Sagent will begin marketing and shipping vinorelbine injection immediately.

"Sagent has launched six products in the third quarter of 2009, including vinorelbine, our third oncolytic product. Our innovative business model enables us to provide our customers with a broad range of products and delivery systems with features designed to help enhance safety and convenience," said Michael Logerfo, corporate vice president of Sagent. "We continue to receive positive feedback from our customers who often consider the enhanced features of our products to be important factors when making their purchasing decisions."

Sagent's vinorelbine injection is offered in 10 mg per 1 mL and 50 mg per 5 mL, latex-free and preservative-free, single-dose vials that incorporate easy-to-read product and dosage information.

About Vinorelbine Injection, USP

Vinorelbine injection is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced non-small cell lung cancer (NSCLC). In patients with Stage IV NSCLC, vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, vinorelbine is indicated in combination with cisplatin.

The package insert, which is available at www.SagentPharma.com, contains detailed information about the indication, complete side effect profile, boxed warnings and prescribing information.

About Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical company focused on developi
'/>"/>

SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
2. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
3. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
4. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
5. Arena Pharmaceuticals to Host Conference Call and Webcast on Friday, September 18, 2009, to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaserin for Weight Management
6. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
7. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
8. In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses
9. MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
10. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
11. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015   HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of advanced ... Godshall , is scheduled to present at the Bank of ... Las Vegas on Thursday, May 14, 2015, at ... webcast of the Company,s presentation at the conference will be ...
(Date:5/4/2015)... CARLSBAD, Calif. , May 4, 2015  Isis ... an exclusive license agreement with Bayer HealthCare (Bayer) to ... of thrombosis. Under the terms of the agreement, Isis ... near-term payments, including an immediate $100 million up-front payment ... program following a Phase 2 study in patients with ...
(Date:5/4/2015)... 4, 2015 MEI Pharma, Inc. (Nasdaq: ... the clinical development of novel therapies for cancer, ... of the Company,s investigational drug candidate ME-344 in ... combined with a tyrosine-kinase inhibitor (TKI). In addition, ... a potent inhibitor of mitochondrial oxidative phosphorylation (OXPHOS) ...
Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
... Nov. 8, 2011 MedBox (Pink Sheets: ... have changed their ticker symbol to MDBX.  The company ... to MedBox. The company is a ... dispensing systems of prescription medicines. The free-standing unit features ...
... 8, 2011 Reportlinker.com announces that a ... its catalogue: European Markets ... http://www.reportlinker.com/p0681077/European-Markets-for-Ophthalmic-Devices-2011-Diagnostic--Invasive.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Ophthalmic_Devices ... interventional ophthalmic device market was valued at ...
Cached Medicine Technology:MedBox Announces Ticker Symbol Change 2European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 2European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 3European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 4European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 5European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 6European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 7European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 8European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 9European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 10European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 11European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 12European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 13European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 14European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 15European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 16European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 17European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 18European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 19European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 20European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive) 21
(Date:5/4/2015)... 2015 EY today announced that Kevin ... finalist for the EY Entrepreneur Of The Year® 2015 ... program recognizes entrepreneurs who demonstrate excellence and extraordinary success ... commitment to their businesses and communities. Mr. MacDonald ... independent judges. Award winners will be announced on ...
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Charlottesville, VA. McCartney is one of the most ... this beloved performer continues to roll along with no signs ... legendary groups: Wings and The Beatles, has been celebrating his ... the “Out There” tour and has continually added new stops ...
(Date:5/4/2015)... May 04, 2015 CCL, a top-ranked, ... this unique program to other leadership development consultancies. “The ... between CCL and successful practitioners, expanding our capacity to ... globe,” said John R. Ryan, CCL President and CEO. ... CCL Partner Network , it will schedule a ...
(Date:5/4/2015)... York, NY (PRWEB) May 04, 2015 ... Hale Learning Center from Hale House. The Mother Hale ... offering high-quality, affordable Early Childhood Education. Sheltering Arms will ... will continue to be served by the center. , ... 45 children ages six weeks to five years, many ...
(Date:5/4/2015)... Unlike some camps, the Nike Middle School Running ... goal is to educate first and train second, with a significant ... the young runners are building the knowledge base needed to have ... topics covered include Effort Based Training, Running Heroes, Running Vocabulary, and ... This is not a camp where kids come to run ...
Breaking Medicine News(10 mins):Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2
... ATLANTA, Feb. 9 While people across the country scrutinize,the ... to octuplets,Jan. 26, eyes also must turn to the fertility ... to the 33-year-old mother, Nadya Suleman, the same physician,treated her ... Today Show,interview that in her last IVF treatment, six embryos ...
... public relations,agency Waggener Edstrom Worldwide (WE) will ... in the Digital World: Mitigating the Risks,in ... take place on,Tuesday, Feb. 24, 9 a.m. ... and be,available via webcast at, http://waggeneredstrom.com/reg/events/healthcare-webcast.aspx . ...
... nuclear magnetic resonance, or SSNMR, is a valuable ... of proteins and other biomolecules. But the imaging ... costly isotope-labeled sample for study. , Yoshitaka Ishii, ... Illinois at Chicago, believes he has found a ...
... nation,s first - and only - program aimed at taking ... ligament (ACL) tears among female high school athletes is working, ... York. The program, called PEP (Prevent injury, Enhance ... knee injuries that can sideline athletic careers among females, who ...
... announced today that it won,first place in Chain Store ... the design of its new prototype store that debuted ... will be profiled in the,magazine,s February issue. , ... across all industry,segments. Designed by leading retail design firm ...
... Lifespan evaluated the research to date on the impact ... review of all relevant randomized, controlled trials shows no ... delay or slow progression of cognitive changes in healthy ... year industry. The study appeared in Alzheimer,s & Dementia. ...
Cached Medicine News:Health News:Fertility Expert Calls Birth of Octuplets 'Criminal' 2Health News:Healthcare Online Regulations to Be Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2Health News:New technique boosts protein NMR imaging speeds 2Health News:ACL Injury Prevention Program is First in Nation to Tackle Growing Problem 2Health News:ACL Injury Prevention Program is First in Nation to Tackle Growing Problem 3Health News:New Shopko Store Design Takes Top Honors 2Health News:New Shopko Store Design Takes Top Honors 3Health News:Study questions effectiveness of $80 million per year 'brain exercise' products industry 2
NephroMax High Pressure Nephrostomy Balloon Catheter (Kit) allows one-step, atraumatic dilatation of the nephrostomy tract....
Used for dilation of a tract to the kidney for removal of stones. Supplied sterile in peel-open packages. Intended for one-time use....
... Programmes are supplied on Smart Cards. Insert the ... treatment starts and turns itself off after the ... and total duration of treatments. Simply provide your ... check on their progress on the next visit.,The ...
... timely, high-quality and accurate,ECG results ... The,Quinton Eclipse Premier allows you ... results,and make a diagnosis quicker ... capabilities.,Workload is further streamlined with ...
Medicine Products: